Status:

ACTIVE_NOT_RECRUITING

Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry

Lead Sponsor:

Biocells Medical

Conditions:

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders

Eligibility:

All Genders

18-70 years

Brief Summary

This retrospective observational study will analyze de-identified clinical data from patients with amyotrophic lateral sclerosis (ALS) collected at multiple centers over 7 years. The primary objective...

Eligibility Criteria

Inclusion

  • Diagnosis of amyotrophic lateral sclerosis (ALS) or motor neuron disease confirmed.
  • Age ≥18 years.
  • Availability of at least one ALS Functional Rating Scale-Revised (ALSFRS-R) score.
  • Availability of longitudinal follow-up data.

Exclusion

  • Patients with alternative diagnoses that mimic ALS (e.g., multifocal motor neuropathy, cervical myelopathy, myasthenia gravis).
  • Absence of medical records

Key Trial Info

Start Date :

May 13 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2028

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT07143656

Start Date

May 13 2021

End Date

September 1 2028

Last Update

August 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Biocells Medical

Warsaw, Poland